CRISPR Therapeutics AG (CRSP) Prepaid Assets (2015 - 2026)

CRISPR Therapeutics AG has disclosed Prepaid Assets across 12 years of filings, most recently posting $6.6 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $6.6 million, down 46.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 million (down 46.64% YoY), and the FY2025 annual result was $9.8 million, up 18.5% from the prior year.
• Prepaid Assets came in at $6.6 million for Q1 2026 at CRISPR Therapeutics AG, down from $9.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $41.7 million in Q2 2022 to a low of $6.6 million in Q1 2026.
• The 5-year median for Prepaid Assets is $13.4 million (2025), against an average of $19.3 million.
• Across the five-year window, Prepaid Assets plunged 61.85% in 2023 and soared 62.28% in 2025, its largest moves.
• CRISPR Therapeutics AG's Prepaid Assets stood at $37.7 million in 2022, then slumped by 61.85% to $14.4 million in 2023, then tumbled by 42.26% to $8.3 million in 2024, then advanced by 18.5% to $9.8 million in 2025, then slumped by 33.18% to $6.6 million in 2026.
• The last three Prepaid Assets figures came in at $6.6 million (Q1 2026), $9.8 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.